−19.0
Moleculin Biotech, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−27.6
FY23:
−23.6
FY24:
−23.9
FY25:
−22.7
Change from FY21 to FY25
millions USD
FY21:
−0.02
FY22:
−0.07
FY23:
−0.12
FY24:
−0.01
FY25:
0
Change from FY21 to FY25
millions USD
FY21:
74.7
FY22:
−0.02
FY23:
4.14
FY24:
4.64
FY25:
27.3
millions USD
FY21:
55.7
FY22:
−27.8
FY23:
−19.6
FY24:
−19.3
FY25:
4.60
(positive)
Change from FY21 to FY25
millions USD
FY21:
−19.0
FY22:
−27.7
FY23:
−23.7
FY24:
−23.9
FY25:
−22.7
All amounts in millions USD